PriceSensitive

Entourage Health (TSXV:ENTG) appoints James Afara as Chief Operating Officer

Cannabis
TSXV:ENTG
16 September 2022 14:30 (EDT)
Entourage Health - Chief Operating Officer, James Afara

Source: LinkedIn

Entourage Health (ENTG) has appointed James Afara as the company’s Chief Operating Officer (COO).

Afara brings over 15 years of operations and supply chain experience to Entourage. Most recently, he served as Entourage’s Senior Vice President of Strategic Sourcing, Quality Assurance and Cultivation.

His promotion has come at a pivotal time. The company is integrating all functional teams in cultivation, tissue culture, production, operations and supply chain under one leader. This will align core competencies and resources for maximum output.

George Scorsis, CEO and Executive Chairman of Entourage commented on the appointment.

“With his proven track record, business acumen and strong management outlook, James is perfectly suited to oversee all functions related to bringing saleable products to market, from seed to sale – straight through to distribution. With the addition of James, we have solidified and further strengthened our management team that will be pivotal to meeting our revenue and profitability goals in the near term.”

Prior to joining Entourage in late 2021, James served as the COO at CannTx Life Sciences. He is a professional engineer by trade. James is widely recognized for his business analytics strategies that helped commercialize proprietary tissue culture remediation services and brought forward automated-operations activities for cannabis produced both in small batches and at scale.

Over the past 15 years, James held manufacturing-related leadership roles of increased responsibilities at SteriPro Canada and Maple Leaf Foods. He holds a Bachelor of Science, Biochemical Engineering Degree from Western University. He has also completed Leadership Certification courses from the Ivy School of Business.

Entourage Health is a licensed producer and distributor of cannabis products for both the medical and adult-use markets.

Entourage Health Corp. (ENTG) opened trading at C$0.04 per share.


Related News